Royal Bank Of Canada restated their outperform rating on shares of Concordia Healthcare Corp (TSE:CXR) in a research note issued to investors on Tuesday, StockTargetPrices.com reports. They currently have a C$18.50 price objective on the stock.
Other equities research analysts also recently issued research reports about the company. Goldman Sachs Group Inc. dropped their target price on Concordia Healthcare Corp from C$34.00 to C$17.00 in a report on Monday, August 15th. TD Securities dropped their target price on Concordia Healthcare Corp from C$45.00 to C$37.00 and set a buy rating for the company in a report on Tuesday, June 28th. Finally, CIBC downgraded Concordia Healthcare Corp from a sector perform rating to an underperform rating in a report on Monday, August 15th. One analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company. The company has an average rating of Hold and an average price target of C$27.38.
Concordia Healthcare Corp (TSE:CXR) opened at 5.72 on Tuesday. Concordia Healthcare Corp has a 12 month low of $5.64 and a 12 month high of $58.75. The company’s market cap is $291.82 million. The company’s 50-day moving average is $8.42 and its 200-day moving average is $24.53.
About Concordia Healthcare Corp
Receive News & Ratings for Concordia Healthcare Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concordia Healthcare Corp and related companies with MarketBeat.com's FREE daily email newsletter.